Analytical Data
-
Gene name
TUSC2
- Application
-
Alternative Names
TUSC2；C3orf11；Tumor suppressor candidate 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O75896
-
Expression Region
1-110aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMGASGSK ARGLWPFASA AGGGGSEAAG AEQALVRPRG RAVPPFVFTR RGSMFYDEDG DLAHEFYEET IVTKNGQKRA KLRRVHKNLI PQGIVKLDHP RIHVDFPVIL YEV
-
Molecular Weight
15 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TUSC2, also known as tumor suppressor candidate 2, is a gene that encodes a protein implicated in several cellular processes, including apoptosis, cell cycle regulation, and response to stress. Research into TUSC2 has gained traction due to its potential role in cancer biology, particularly in lung cancer, where downregulation or loss of TUSC2 expression has been associated with poor prognosis and tumor progression. Studies have suggested that TUSC2 functions as a tumor suppressor by modulating signaling pathways crucial for cell survival and proliferation. The investigation of TUSC2 as a recombinant protein is of particular interest because it offers the opportunity to explore its structural and functional properties in detail. Furthermore, understanding the mechanisms by which TUSC2 exerts its tumor suppressive effects may provide insights into novel therapeutic approaches for cancer treatment. Recombinant TUSC2 can be utilized in various experimental settings to examine its interaction with other proteins, its role in cell signaling pathways, and its effect on cellular behaviors like migration and invasion. Overall, the study of TUSC2 and its recombinant form represents a promising avenue for advancing our knowledge of cancer biology and developing targeted therapies.
